Risk of Developing Pediatric Uveitis Among Patients With Early-Onset Atopic Dermatitis

Atopic Dermatitis

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib

Acta Derm Venereol

Kwatra SG, De Bruin-Weller M, Silverberg JI, Lio P, Deleuran M, Aydin H, Calimlim BM, Lane MC, Liu Y, Ofori S, Weidinger S

doi: 10.2340/actadv.v104.18452

Atopic DermatitisPsoriasis

Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe

J Eur Acad Dermatol Venereol

Ziehfreund S, Wecker H, Mittag S, Weis J, Tizek L, Verkhoturova V, Legat FJ, Weger W, Großschädl K, Cerpes U, Sadoghi B, Riegler M, Balato A, Di Brizzi EV, Buononato D, Babino G, Calzavara-Pinton P, Rossi MT, Rovaris S, Dimech A, Boffa MJ, Chernyshov P, Svyatenko T, Kolodzinska L, Sikora M, Torres T, Manolache L, Scala E, Biedermann T, Zink A

doi: 10.1111/jdv.20288

Atopic Dermatitis

Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials

Adv Ther

Ständer S, Yosipovitch G, Simpson EL, Kim BS, Kabashima K, Thaçi D, Metz M, Chen Z, Hagen S, Bastian M

doi: 10.1007/s12325-025-03124-8

Juvenile Idiopathic Arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Arthritis Rheumatol

Tordoff M, Smith SL, Lawson-Tovey S, UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC, Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J, CLUSTER consortium

doi: 10.1002/art.42955

Atopic Dermatitis

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

J Am Acad Dermatol

Zhang J, Boesjes CM, Loman L, Kamphuis E, Romeijn MLE, Spekhorst LS, Haeck I, van der Gang LF, Dekkers CC, van der Rijst LP, Oosting AJ, van Lumig P, van Lynden-van Nes AMT, Tupker RA, Nijssen A, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, de Graaf M, de Bruin-Weller MS, Schuttelaar MA

doi: 10.1016/j.jaad.2024.04.026

Allergic Diseases

Assessing contact dermatitis risk among Manitoba workers in the Manitoba Occupational Disease Surveillance System

Contact Dermatitis

Rydz E, Walld R, Quinn EK, Koehoorn MW, McLeod CB, Demers PA, Peters CE, Kraut A

doi: 10.1111/cod.14674

Allergic Diseases

Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

Contact Dermatitis

Chicharro P, Munera-Campos M, Zaragoza-Ninet V, Giménez-Arnau A, González-Pérez R, Miquel-Miquel FJ, Córdoba-Guijarro S, Sanz-Sánchez T, Ruiz-González I, Silvestre-Salvador JF, Serra-Baldrich E, Borrego L, Pastor-Nieto MA, Ortiz de Frutos FJ, Mercader-García P, Heras-Mendaza F, Fernández-Redondo V, Rodríguez-Serna M, Hervella-García M, Carrascosa JM, Gallego-Descalzo MA, García-Doval I, Sánchez-Pérez J

doi: 10.1111/cod.14672

Atopic Dermatitis

Switching from dupilumab to tralokinumab or Janus kinase inhibitors in cases of ocular and/or facial adverse events in patients with atopic dermatitis: a multicenter retrospective study

J Allergy Clin Immunol Pract

Beyrouti A, Deuze J, Fontas E, Foureau A, Barbarot S, Aubert H, Bernier C, Le Moigne M, Passeron T, Boukari F, Garnier M, Jachiet M, Tetart F, Seneschal J, Toussaint C, Mahé E, Leleu C, Regnault MM, Pasteur J, Nosbaum A, Badaoui A, Fougerousse AC, Pralong P, Viguier M, Droitcourt C, Abasq C, Mallet S, Raison-Peyron N, Staumont-Sallé D, Hubiche T, FRench Atopic DErmatitis Network (FRADEN) from the Groupe de Recherche sur l’Eczéma Atopique (GREAT) Research Group

doi: 10.1016/j.jaip.2024.12.001

Allergic Diseases

Contact sensitization to fragrance mix I and fragrance mix II among European dermatitis patients: A systematic review

Contact Dermatitis

Botvid S, Bennike NH, Simonsen AB, Johansen JD, Uter W

doi: 10.1111/cod.14618

Related content

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib

Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe

Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

Assessing contact dermatitis risk among Manitoba workers in the Manitoba Occupational Disease Surveillance System

Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

Switching from dupilumab to tralokinumab or Janus kinase inhibitors in cases of ocular and/or facial adverse events in patients with atopic dermatitis: a multicenter retrospective study

Contact sensitization to fragrance mix I and fragrance mix II among European dermatitis patients: A systematic review